Existing treatments Are current medications (e.g., GLP-1 agonists, SGLT-2 inhibitors) already addressing metabolic risk factors, and how effective have they been
[DOI] [PubMed] [Google Scholar] 13.Cousen P, Colver G, Helbling I
25 , 10911102.e1094 (2017)
These findings underscore the developmental importance of early microbial signals in shaping neural circuits and behavior, processes modulated by molecules such as reelin, which controls dendritic growth and synaptic receptor function in post-natal entorhinal cortex neurons (Hamad et al., 2021b,a, 2024b,a
GLP-1 medications like Foundayo may improve insulin sensitivity in the brain, support healthier neuron functions, and potentially slow cognitive decline
What states does MadeMed serve